UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 93

Sortiert nach

Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase

Proceedings of the Japan Academy, Series B, 2017/08/02, Vol.93(7), pp.449-463

2017

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of Favipiravir (T-705) in Rabies Postexposure Prophylaxis

The Journal of infectious diseases, 2016-04, Vol.213 (8), p.1253-1261

2016

Link zum Volltext

Verfügbarkeit prüfen

Mechanism of Action of T-705 Ribosyl Triphosphate against Influenza Virus RNA Polymerase

Antimicrobial Agents and Chemotherapy, 2013-11, Vol.57 (11), p.5202-5208

2013

Link zum Volltext

Verfügbarkeit prüfen

Use of Favipiravir to Treat Lassa Virus Infection in Macaques

Emerging infectious diseases, 2018-09, Vol.24 (9), p.1696-1699

2018

Link zum Volltext

Verfügbarkeit prüfen

Favipiravir (T-705) protects against Nipah virus infection in the hamster model

Scientific reports, 2018-05, Vol.8 (1), p.7604-11, Article 7604

2018

Link zum Volltext

Verfügbarkeit prüfen

The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset

Scientific reports, 2015-10, Vol.5 (1), p.14775-14775, Article 14775

2015

Link zum Volltext

Verfügbarkeit prüfen

Antiviral susceptibility of influenza viruses isolated from patients pre- and post-administration of favipiravir

Antiviral research, 2016-08, Vol.132, p.170-177

2016

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic effects of favipiravir against severe fever with thrombocytopenia syndrome virus infection in a lethal mouse model: Dose-efficacy studies upon oral administration

PloS one, 2018-10, Vol.13 (10), p.e0206416

2018

Link zum Volltext

Verfügbarkeit prüfen

Reevaluation of the efficacy of favipiravir against rabies virus using in vivo imaging analysis

Antiviral research, 2019-12, Vol.172, p.104641-104641, Article 104641

2019

Link zum Volltext

Verfügbarkeit prüfen

Antiviral Efficacy of Favipiravir against Two Prominent Etiological Agents of Hantavirus Pulmonary Syndrome

Antimicrobial Agents and Chemotherapy, 2013-10, Vol.57 (10), p.4673-4680

2013

Link zum Volltext

Verfügbarkeit prüfen

T-705 (favipiravir) activity against lethal H5N1 influenza A viruses

Proceedings of the National Academy of Sciences - PNAS, 2010-01, Vol.107 (2), p.882-887

2010

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of a novel severe combined immunodeficiency mouse model for antiviral drug evaluation against Chandipura virus infection

Antiviral research, 2023-05, Vol.213, p.105582-105582, Article 105582

2023

Link zum Volltext

Verfügbarkeit prüfen

Mechanism of Action of T-705 against Influenza Virus

Antimicrobial Agents and Chemotherapy, 2005-03, Vol.49 (3), p.981-986

2005

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of favipiravir (T-705) against Crimean-Congo hemorrhagic fever virus infection in cynomolgus macaques

Antiviral research, 2020-09, Vol.181, p.104858-104858, Article 104858

2020

Link zum Volltext

Verfügbarkeit prüfen

Activity of T-705 in a Hamster Model of Yellow Fever Virus Infection in Comparison with That of a Chemically Related Compound, T-1106

Antimicrobial Agents and Chemotherapy, 2009-01, Vol.53 (1), p.202-209

2009

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Antiviral Activity of Favipiravir (T-705) against Drug-Resistant Influenza and 2009 A(H1N1) Viruses

Antimicrobial Agents and Chemotherapy, 2010-06, Vol.54 (6), p.2517-2524

2010

Link zum Volltext

Verfügbarkeit prüfen

In Vitro and In Vivo Activities of T-705 against Arenavirus and Bunyavirus Infections

Antimicrobial Agents and Chemotherapy, 2007-09, Vol.51 (9), p.3168-3176

2007

Link zum Volltext

Verfügbarkeit prüfen

Favipiravir treatment prolongs the survival in a lethal mouse model intracerebrally inoculated with Jamestown Canyon virus

PLoS neglected tropical diseases, 2021-07, Vol.15 (7), p.e0009553-e0009553

2021

Link zum Volltext

Verfügbarkeit prüfen

Low-dose ribavirin potentiates the antiviral activity of favipiravir against hemorrhagic fever viruses

Antiviral research, 2016-02, Vol.126, p.62-68

2016

Link zum Volltext

Verfügbarkeit prüfen

Effects of the Combination of Favipiravir (T-705) and Oseltamivir on Influenza A Virus Infections in Mice

Antimicrobial Agents and Chemotherapy, 2010-01, Vol.54 (1), p.126-133

2010

Link zum Volltext

Verfügbarkeit prüfen

Heartland virus infection in hamsters deficient in type I interferon signaling: Protracted disease course ameliorated by favipiravir

Virology (New York, N.Y.), 2017-11, Vol.511, p.175-183

2017

Link zum Volltext

Verfügbarkeit prüfen

Alterations in favipiravir (T-705) pharmacokinetics and biodistribution in a hamster model of viral hemorrhagic fever

Antiviral research, 2015-09, Vol.121, p.132-137

2015

Link zum Volltext

Verfügbarkeit prüfen

M Segment-Based Minigenome System of Severe Fever with Thrombocytopenia Syndrome Virus as a Tool for Antiviral Drug Screening

Viruses, 2021-06, Vol.13 (6), p.1061

2021

Link zum Volltext

Verfügbarkeit prüfen

Effective oral favipiravir (T-705) therapy initiated after the onset of clinical disease in a model of arenavirus hemorrhagic Fever

PLoS neglected tropical diseases, 2011-10, Vol.5 (10), p.e1342

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 93

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(84)
Mit Volltextzugriff
(89)

Publikationsform

Artikel
(93)

Sprache

Englisch
(88)
Japanisch
(36)

Erscheinungsjahr

n.n

Thema

Science & Technology
(65)
Life Sciences & Biomedicine
(51)
Animals
(47)
Pharmacology & Pharmacy
(29)
Antiviral Agents
(27)
Virology
(27)
Antiviral Agents - Pharmacology
(24)
Pyrazines - Pharmacology
(23)
Amides - Pharmacology
(22)
Biological And Medical Sciences
(22)
Medical Sciences
(22)
Amides - Therapeutic Use
(21)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(21)
Antiviral Agents - Therapeutic Use
(21)
Pharmacology. Drug Treatments
(21)
Pyrazines - Therapeutic Use
(21)
Favipiravir
(20)
Humans
(20)
Infectious Diseases
(20)
Disease Models, Animal
(19)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase

Efficacy of Favipiravir (T-705) in Rabies Postexposure Prophylaxis

Mechanism of Action of T-705 Ribosyl Triphosphate against Influenza Virus RNA Polymerase

Use of Favipiravir to Treat Lassa Virus Infection in Macaques

Favipiravir (T-705) protects against Nipah virus infection in the hamster model

The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset

Antiviral susceptibility of influenza viruses isolated from patients pre- and post-administration of favipiravir

Therapeutic effects of favipiravir against severe fever with thrombocytopenia syndrome virus infection in a lethal mouse model: Dose-efficacy studies upon oral administration

Reevaluation of the efficacy of favipiravir against rabies virus using in vivo imaging analysis

Antiviral Efficacy of Favipiravir against Two Prominent Etiological Agents of Hantavirus Pulmonary Syndrome

T-705 (favipiravir) activity against lethal H5N1 influenza A viruses

Evaluation of a novel severe combined immunodeficiency mouse model for antiviral drug evaluation against Chandipura virus infection

Mechanism of Action of T-705 against Influenza Virus

Efficacy of favipiravir (T-705) against Crimean-Congo hemorrhagic fever virus infection in cynomolgus macaques

Activity of T-705 in a Hamster Model of Yellow Fever Virus Infection in Comparison with That of a Chemically Related Compound, T-1106

In Vitro Antiviral Activity of Favipiravir (T-705) against Drug-Resistant Influenza and 2009 A(H1N1) Viruses

In Vitro and In Vivo Activities of T-705 against Arenavirus and Bunyavirus Infections

Favipiravir treatment prolongs the survival in a lethal mouse model intracerebrally inoculated with Jamestown Canyon virus

Low-dose ribavirin potentiates the antiviral activity of favipiravir against hemorrhagic fever viruses

Effects of the Combination of Favipiravir (T-705) and Oseltamivir on Influenza A Virus Infections in Mice

Heartland virus infection in hamsters deficient in type I interferon signaling: Protracted disease course ameliorated by favipiravir

Susceptibility of Type I Interferon Receptor Knock-Out Mice to Heartland Bandavirus (HRTV) Infection and Efficacy of Favipiravir and Ribavirin in the Treatment of the Mice Infected with HRTV

Alterations in favipiravir (T-705) pharmacokinetics and biodistribution in a hamster model of viral hemorrhagic fever

M Segment-Based Minigenome System of Severe Fever with Thrombocytopenia Syndrome Virus as a Tool for Antiviral Drug Screening

Effective oral favipiravir (T-705) therapy initiated after the onset of clinical disease in a model of arenavirus hemorrhagic Fever

Suchergebnisse filtern